Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)

This study has been completed.
Muscular Dystrophy Association
Information provided by:
VA Office of Research and Development Identifier:
First received: April 7, 2005
Last updated: January 8, 2010
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)